Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis

Mensen, VT, Vreeker, A, Nordgren, J, Atkinson, AM, de la Torre, R, Farré, M, Ramaekers, JG and Brunt, TM (2019) Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. Psychopharmacology. ISSN 0033-3158

Full text not available from this repository. Please see publisher or open access link below:
Open Access URL: https://doi.org/10.1007/s00213-019-05238-8 (Published version)

Abstract

Background: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many different synthetic cannabinoid analogues are on the consumer market and sold under misleading names, like “spice” or “incense.” A limited number of studies have reported serious health effects associated with SC use. In this study, we compared clinical and subclinical psychopathological symptoms associated with SC use and natural cannabis (NC) use.
Methods: A convenience sample of 367 NC and SC users was recruited online, including four validated psychometric questionnaires: The Drug Use Disorders Identification Test (DUDIT), Insomnia Severity Index (ISI), Altman Mania Scale (Altman), and Brief Symptom Inventory (BSI). The two groups were compared with analysis of variance (ANOVA) and covariance (ANCOVA), chi2 tests, and logistic regression when appropriate.
Results: The SC user group did not differ in age from the NC user group (27.7 years), but contained less females (21% and 30%, respectively). SC users scored higher than NC users on all used psychometric measures, indicating a higher likelihood of drug abuse, sleep problems, (hypo)manic symptoms, and the nine dimensions comprising the BSI, somatization, obsessive-compulsive behavior, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. Odds ratios (95% CI) for the SC user group vs NC user group were, respectively, drug dependence 3.56 (1.77–7.16), (severe) insomnia 5.01 (2.10–11.92), (hypo-)mania 5.18 (2.04–13.14), and BSI psychopathology 5.21 (2.96–9.17).
Discussion: This study shows that SC use is associated with increased mental health symptomatology compared to NC use.

Item Type: Article
Uncontrolled Keywords: 11 Medical and Health Sciences, 17 Psychology and Cognitive Sciences
Subjects: B Philosophy. Psychology. Religion > BF Psychology
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Public Health Institute
Publisher: Springer Nature
Date Deposited: 14 May 2019 10:03
Last Modified: 14 May 2019 10:03
DOI or Identification number: 10.1007/s00213-019-05238-8
URI: http://researchonline.ljmu.ac.uk/id/eprint/10685

Actions (login required)

View Item View Item